157 related articles for article (PubMed ID: 36459118)
1. Cannabis Advertising Policies in the United States: State-Level Variation and Comparison with Canada.
Allard NC; Kruger JS; Kruger DJ
Cannabis Cannabinoid Res; 2023 Jun; 8(3):505-509. PubMed ID: 36459118
[No Abstract] [Full Text] [Related]
2. Analysis of social media compliance with cannabis advertising regulations: evidence from recreational dispensaries in Illinois 1-year post-legalization.
Marinello S; Valek R; Powell LM
J Cannabis Res; 2024 Jan; 6(1):2. PubMed ID: 38173010
[TBL] [Abstract][Full Text] [Related]
3. Cannabis advertising impacts on youth cannabis use intentions following recreational legalization in Canada: An Ecological Momentary Assessment (EMA) study.
Noël C; Scharf D; Koné A; Armiento C; Dylan D
Addict Behav; 2024 Jun; 153():107981. PubMed ID: 38367505
[TBL] [Abstract][Full Text] [Related]
4. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America.
Goundar P; Macaulay T; Szafron M
Int J Drug Policy; 2021 Aug; 94():103191. PubMed ID: 33756442
[TBL] [Abstract][Full Text] [Related]
6. A review of social media platform policies that address cannabis promotion, marketing and sales.
Berg CJ; LoParco CR; Cui Y; Pannell A; Kong G; Griffith L; Romm KF; Yang YT; Wang Y; Cavazos-Rehg PA
Subst Abuse Treat Prev Policy; 2023 Jun; 18(1):35. PubMed ID: 37337216
[TBL] [Abstract][Full Text] [Related]
7. Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms.
Sheikhan NY; Pinto AM; Nowak DA; Abolhassani F; Lefebvre P; Duh MS; Witek TJ
JAMA Netw Open; 2021 Jul; 4(7):e2116551. PubMed ID: 34251442
[TBL] [Abstract][Full Text] [Related]
8. Cannabis advertising, promotion and branding: Differences in consumer exposure between 'legal' and 'illegal' markets in Canada and the US.
Rup J; Goodman S; Hammond D
Prev Med; 2020 Feb; 133():106013. PubMed ID: 32027914
[TBL] [Abstract][Full Text] [Related]
9. Cannabis Policy in the United States: Implications for Public Health.
Schauer GL
J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):39-52. PubMed ID: 34850901
[TBL] [Abstract][Full Text] [Related]
10. Cannabis Retailer Communication About Cannabis Products, Health Benefits, and Risks: A Mystery Shopper Study of Licensed Retailers in Five U.S. Cities.
Romm KF; Cavazos-Rehg PA; Williams R; Dopke C; Cui Y; LoParco CR; Wang Y; Duan Z; Yang YT; Burris S; Berg CJ
J Stud Alcohol Drugs; 2024 Jan; 85(1):100-108. PubMed ID: 37917012
[TBL] [Abstract][Full Text] [Related]
11. The impact of plain packaging and health warnings on consumer appeal of cannabis products.
Goodman S; Leos-Toro C; Hammond D
Drug Alcohol Depend; 2019 Dec; 205():107633. PubMed ID: 31678837
[TBL] [Abstract][Full Text] [Related]
12. When prohibition works: Comparing fireworks and cannabis regulations, markets, and harms.
Caulkins JP; Reimer KV
Int J Drug Policy; 2023 Aug; 118():104081. PubMed ID: 37315476
[TBL] [Abstract][Full Text] [Related]
13. A Content Analysis of Cannabis Company Adherence to Marketing Requirements in Four States.
Moreno MA; Jenkins M; Binger K; Kelly L; Trangenstein PJ; Whitehill JM; Jernigan DH
J Stud Alcohol Drugs; 2022 Jan; 83(1):27-36. PubMed ID: 35040757
[TBL] [Abstract][Full Text] [Related]
14. Cannabis retailer marketing strategies and regulatory compliance: A surveillance study of retailers in 5 US cities.
Berg CJ; Romm KF; Pannell A; Sridharan P; Sapra T; Rajamahanty A; Cui Y; Wang Y; Yang YT; Cavazos-Rehg PA
Addict Behav; 2023 Aug; 143():107696. PubMed ID: 36966547
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
[TBL] [Abstract][Full Text] [Related]
16. Marijuana advertising exposure among current marijuana users in the U.S.
Krauss MJ; Sowles SJ; Sehi A; Spitznagel EL; Berg CJ; Bierut LJ; Cavazos-Rehg PA
Drug Alcohol Depend; 2017 May; 174():192-200. PubMed ID: 28365173
[TBL] [Abstract][Full Text] [Related]
17. Medical Cannabis in Canadian Schools: A Scoping Review of Existing Policies.
Awal M; Kelly LE; Anderson J; Brace T; Brown C; Buettner T; King PM; Klemmer J; Lougheed T; O'Shea K; Mansell H
Cannabis Cannabinoid Res; 2022 Dec; 7(6):758-768. PubMed ID: 36251467
[No Abstract] [Full Text] [Related]
18. Cannabis Industry Marketing Violations in Washington State, 2014-2019.
Carlini BH; Garrett S; Firth C; Pinsky I
J Stud Alcohol Drugs; 2022 Jan; 83(1):18-26. PubMed ID: 35040756
[TBL] [Abstract][Full Text] [Related]
19. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.
Mintzes B; Morgan S; Wright JM
PLoS One; 2009 May; 4(5):e5699. PubMed ID: 19479084
[TBL] [Abstract][Full Text] [Related]
20. Review of cannabis reimbursement by workers' compensation insurance in the U.S. and Canada.
Howard J; Wurzelbacher S; Osborne J; Wolf J; Ruser J; Chadarevian R
Am J Ind Med; 2021 Dec; 64(12):989-1001. PubMed ID: 34532872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
